Skip to main content
Funded Studies

Bob M. Moore, PhD

Professor at University of Tennessee Health Science Center

Location: Memphis, TN United States

Bob M. Moore II is a medicinal chemist with over 15 years of experience in the design, synthesis, and pre-clinical evaluation of cannabinoid based therapeutic agents. He has developed eight novel classes of cannabinoid receptor 1 and 2 (CB1 and CB2) ligands resulting in 19 U.S. patents for composition of matter and methods of use. The current focus of Dr. Moore’s research is the development of CB2 inverse agonists to treat neuroinflammation associated with microglia activation.

Associated Grants

  • Modulation of Microglia Cannabinoid Receptor 2 to Treat Neuroinflammation in Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.